Anti-HBc screening in Indian blood donors: Still an unresolved issue

World Journal of Gastroenterology

Volumn 14, Issue 34, 2008, Pages 5327-5330

  Dhawan, Hari Krishan ^a   Marwaha, Neelam ^a   Sharma, Ratti Ram ^a   Chawla, Yogesh ^a   Thakral, Beenu ^a   Saluja, Karan ^a   Sharma, Sanjeev Kumar ^a   Thakur, Manish K ^a   Jain, Ashish ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Blood donors; Hepatitis B core antigen; Hepatitis B surface antigen; Hepatitis B virus; Transfusion associated hepatitis B virus

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; PRIMER DNA;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; INDIA; LIVER FUNCTION TEST; MALE; POLYMERASE CHAIN REACTION; SCREENING TEST; SEROPREVALENCE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; MASS SCREENING; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BLOOD DONORS; DNA PRIMERS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INDIA; MASS SCREENING; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES;

EID: 64849093543     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5327     Document Type: Article

References (17)

1. Schmidt M, Nubling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang 2006; 91: 237-243
2. Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003; 43: 1442-1448
3. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang 1997; 73: 70-73
4. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Nojiri N, Juji T, Hoshino H, Shimoda K, Hino K, Kimura S, Iino S, Koike K. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001; 41: 1093-1099
5. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704
6. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47: 74-79
7. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13: 3730-3733
8. Malik V. Drugs and Cosmetics Act, 1940. 16th ed. Lucknow: Eastern Book Company, 2003: 279-303
9. Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight. Transfusion 2001; 41: 1081-1085
10. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 2006; 123: 37-42
11. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86: 83-91
12. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91: 1-12
13. Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N, Agnihotri SK. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India 2004; 17: 19-21
14. Glynn SA, Schreiber GB, Busch MP, Kleinman SH, Williams AE, Nass CC, Ownby HE, Smith JW. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1998; 38: 350-358
15. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277: 967-972
16. Schreiber GB, Glynn SA, Busch MP, Sharma UK, Wright DJ, Kleinman SH. Incidence rates of viral infections among repeat donors:are frequent donors safer? Transfusion 2001; 41: 730-735
17. Duseja A, Sharma S, Subramanian PG, Agnihotri SK, Chakraborti A, Chawla Y. Occult hepatitis B virus (HBV) infection in healthy blood donors. Indian J Pathol Microbiol 2003; 46: 690-692